1575591-71-7 Usage
Uses
Used in Medicinal Chemistry:
2-methyl-2-(4-oxetan-3-yl-piperazin-1-yl)-propionaldehyde is utilized as a key intermediate in the synthesis of various pharmaceutical agents. Its unique structural components, including the piperazine ring and the 2-methyl-2-oxetanyl group, contribute to the development of novel drug candidates with potential therapeutic applications.
Used in Drug Development:
In the pharmaceutical industry, 2-methyl-2-(4-oxetan-3-yl-piperazin-1-yl)-propionaldehyde serves as a building block for the creation of new drugs. Its chemical properties allow for the design of molecules with specific biological activities, targeting a range of medical conditions.
Used in Biochemical Research:
2-methyl-2-(4-oxetan-3-yl-piperazin-1-yl)-propionaldehyde is employed as a research tool in biochemical studies. Its reactivity and interaction with biological systems provide insights into the mechanisms of action of various biologically active compounds, aiding in the understanding of their effects and potential applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 1575591-71-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,7,5,5,9 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1575591-71:
(9*1)+(8*5)+(7*7)+(6*5)+(5*5)+(4*9)+(3*1)+(2*7)+(1*1)=207
207 % 10 = 7
So 1575591-71-7 is a valid CAS Registry Number.
1575591-71-7Relevant academic research and scientific papers
PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS
-
Page/Page column 86-87, (2014/03/26)
The present disclosure provides compounds of Formula (LA) and/ or pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular BTK, and are potentially useful for the treatment of diseases treatable by inhibition of ty r-osine kinases such as cancer, inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and/or pharmaceutically acceptable salts thereof and processes for preparing such compounds and p h ar-maceutically acceptable salts thereof
